Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Boguniewicz

TitleAffiliate - NJH
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Li S, Villarreal M, Stewart S, Choi J, Indra G, Babineau DC, Philpot C, David G, Yoshida T, Boguniewicz M, Hanifin J, Beck LA, Leung D, Simpson E, Indra AK. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis. Br J Dermatol. 2017 Feb 28. PMID: 28244066.
      View in: PubMed
    2. Nicol NH, Boguniewicz M. Wet Wrap Therapy in Moderate to Severe Atopic Dermatitis. Immunol Allergy Clin North Am. 2017 Feb; 37(1):123-139. PMID: 27886902.
      View in: PubMed
    3. Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016 Sep; 75(3):494-503.e6. PMID: 27417017.
      View in: PubMed
    4. Chen JK, Jacob SE, Nedorost ST, Hanifin JM, Simpson EL, Boguniewicz M, Watsky KL, Lugo-Somolinos A, Hamann CR, Eberting CL, Silverberg JI, Thyssen JP. A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion. Dermatitis. 2016 Jul-Aug; 27(4):186-92. PMID: 27427820.
      View in: PubMed
    5. Schneider L, Hanifin J, Boguniewicz M, Eichenfield LF, Spergel JM, Dakovic R, Paller AS. Study of the Atopic March: Development of Atopic Comorbidities. Pediatr Dermatol. 2016 Jul; 33(4):388-98. PMID: 27273433.
      View in: PubMed
    6. Meadows S, Fending D, Boguniewicz M. Collaboration in best practices for care of patients with atopic dermatitis. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):347-9.e1. PMID: 26755101.
      View in: PubMed
    7. Spergel JM, Boguniewicz M, Schneider L, Hanifin JM, Paller AS, Eichenfield LF. Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements. Pediatrics. 2015 Dec; 136(6):e1530-8. PMID: 26598458.
      View in: PubMed
    8. Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, Block JK, Feldman SR, Clark AR, Tofte S, Dunn JD, Paller AS. Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers. Pediatrics. 2015 Sep; 136(3):554-65. PMID: 26240216.
      View in: PubMed
    9. Bhanegaonkar A, Horodniceanu EG, Ji X, Detzel P, Boguniewicz M, Chamlin S, Lake A, Czerkies LA, Botteman MF, Saavedra JM. Economic Burden of Atopic Dermatitis in High-Risk Infants Receiving Cow's Milk or Partially Hydrolyzed 100% Whey-Based Formula. J Pediatr. 2015 May; 166(5):1145-1151.e3. PMID: 25919724.
      View in: PubMed
    10. Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015 Jun; 26(4):306-15. PMID: 25557211; PMCID: PMC4657476.
    11. Sigurgeirsson B, Boznanski A, Todd G, Vertruyen A, Schuttelaar ML, Zhu X, Schauer U, Qaqundah P, Poulin Y, Kristjansson S, von Berg A, Nieto A, Boguniewicz M, Paller AS, Dakovic R, Ring J, Luger T. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 2015 Apr; 135(4):597-606. PMID: 25802354.
      View in: PubMed
    12. Boguniewicz M, Leung DY. Targeted therapy for allergic diseases: at the intersection of cutting-edge science and clinical practice. J Allergy Clin Immunol. 2015 Feb; 135(2):354-6. PMID: 25662304.
      View in: PubMed
    13. Boguniewicz M. Atopic dermatitis: the updated practice parameter and beyond. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):429-34. PMID: 25584909.
      View in: PubMed
    14. Nicol NH, Boguniewicz M, Strand M, Klinnert MD. Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract. 2014 Jul-Aug; 2(4):400-6. PMID: 25017527.
      View in: PubMed
    15. Mathias RA, Weinberg A, Boguniewicz M, Zaccaro DJ, Armstrong B, Schneider LC, Hata TR, Hanifin JM, Beck LA, Barnes KC, Leung DY. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-?-producing CD8+ T cells. Br J Dermatol. 2013 Sep; 169(3):700-3. PMID: 23600999.
      View in: PubMed
    16. Saavedra JM, Boguniewicz M, Chamlin S, Lake A, Nedorost S, Czerkies LA, Patel V, Botteman MF, Horodniceanu EG. Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. J Pediatr. 2013 Dec; 163(6):1747-53. PMID: 23953725.
      View in: PubMed
    17. Boguniewicz M, Leung DY. The ABC's of managing patients with severe atopic dermatitis. J Allergy Clin Immunol. 2013 Aug; 132(2):511-2.e5. PMID: 23905920; PMCID: PMC3785088.
    18. Hata TR, Audish D, Kotol P, Coda A, Kabigting F, Miller J, Alexandrescu D, Boguniewicz M, Taylor P, Aertker L, Kesler K, Hanifin JM, Leung DY, Gallo RL. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014 Jun; 28(6):781-9. PMID: 23638978; PMCID: PMC3769441.
    19. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013 Feb; 131(2):295-9.e1-27. PMID: 23374261.
      View in: PubMed
    20. Bergmann MM, Caubet JC, Boguniewicz M, Eigenmann PA. Evaluation of food allergy in patients with atopic dermatitis. J Allergy Clin Immunol Pract. 2013 Jan; 1(1):22-8. PMID: 24229818.
      View in: PubMed
    21. Gaffin JM, Spergel JM, Boguniewicz M, Eichenfield LF, Paller AS, Fowler JF, Dinulos JG, Tilles SA, Schneider LC, Phipatanakul W. Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis. Allergy Asthma Proc. 2012 May-Jun; 33(3):282-8. PMID: 22584195; PMCID: PMC3354731.
    22. Boguniewicz M. New strategies for dealing with Staphylococcus aureus colonization and the emerging methicillin-resistant Staphylococcus aureus epidemic in atopic dermatitis. Chem Immunol Allergy. 2012; 96:113-9. PMID: 22433380.
      View in: PubMed
    23. Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol. 2012 Mar; 132(3 Pt 1):650-7. PMID: 22113474; PMCID: PMC3278591.
    24. Howell MD, Gao P, Kim BE, Lesley LJ, Streib JE, Taylor PA, Zaccaro DJ, Boguniewicz M, Beck LA, Hanifin JM, Schneider LC, Hata TR, Gallo RL, Kaplan MH, Barnes KC, Leung DY. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections. J Allergy Clin Immunol. 2011 Nov; 128(5):1006-14. PMID: 21762972; PMCID: PMC3205328.
    25. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011 Jul; 242(1):233-46. PMID: 21682749; PMCID: PMC3122139.
    26. De Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Johnson DC, Barnes KC, Leung DY, Beck LA. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol. 2011 Jul; 128(1):242-246.e5. PMID: 21489616; PMCID: PMC3129463.
    27. Leung DY, Gao PS, Grigoryev DN, Rafaels NM, Streib JE, Howell MD, Taylor PA, Boguniewicz M, Canniff J, Armstrong B, Zaccaro DJ, Schneider LC, Hata TR, Hanifin JM, Beck LA, Weinberg A, Barnes KC. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-? response. J Allergy Clin Immunol. 2011 Apr; 127(4):965-73.e1-5. PMID: 21458658; PMCID: PMC3074534.
    28. Kim BE, Howell MD, Guttman-Yassky E, Guttman E, Gilleaudeau PM, Cardinale IR, Boguniewicz M, Krueger JG, Leung DY. TNF-a downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-a antagonists to improve skin barrier. J Invest Dermatol. 2011 Jun; 131(6):1272-9. PMID: 21346775.
      View in: PubMed
    29. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011 Mar; 127(3):773-86.e1-7. PMID: 21163515; PMCID: PMC3049863.
    30. Schneider L, Weinberg A, Boguniewicz M, Taylor P, Oettgen H, Heughan L, Zaccaro D, Armstrong B, Holliday A, Leung DY. Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls. J Allergy Clin Immunol. 2010 Dec; 126(6):1306-7.e2. PMID: 20889193; PMCID: PMC2998561.
    31. Boguniewicz M. Preface. Atopic dermatitis. Immunol Allergy Clin North Am. 2010 Aug; 30(3):xv. PMID: 20670811.
      View in: PubMed
    32. Ong PY, Boguniewicz M. Investigational and unproven therapies in atopic dermatitis. Immunol Allergy Clin North Am. 2010 Aug; 30(3):425-39. PMID: 20670823.
      View in: PubMed
    33. Hata TR, Kotol P, Boguniewicz M, Taylor P, Paik A, Jackson M, Nguyen M, Kabigting F, Miller J, Gerber M, Zaccaro D, Armstrong B, Dorschner R, Leung DY, Gallo RL. History of eczema herpeticum is associated with the inability to induce human ß-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis. Br J Dermatol. 2010 Sep; 163(3):659-61. PMID: 20545685; PMCID: PMC2966528.
    34. Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol. 2010 Jun; 125(6):1403-1407.e4. PMID: 20466416; PMCID: PMC2925504.
    35. Fleischer AB, Boguniewicz M. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature. J Drugs Dermatol. 2010 May; 9(5):488-98. PMID: 20480792.
      View in: PubMed
    36. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010 Jan; 125(1):4-13; quiz 14-5. PMID: 20109729; PMCID: PMC2814072.
    37. Grigoryev DN, Howell MD, Watkins TN, Chen YC, Cheadle C, Boguniewicz M, Barnes KC, Leung DY. Vaccinia virus-specific molecular signature in atopic dermatitis skin. J Allergy Clin Immunol. 2010 Jan; 125(1):153-159.e28. PMID: 20109744; PMCID: PMC2814071.
    38. Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Barnes KC, Leung DY. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009 Sep; 124(3):507-13, 513.e1-7. PMID: 19733298.
      View in: PubMed
    39. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2009 Sep; 124(3 Suppl 2):R7-R12. PMID: 19720210.
      View in: PubMed
    40. Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009 Aug; 124(2):260-9, 269.e1-7. PMID: 19541356; PMCID: PMC3056058.
    41. Nicol NH, Boguniewicz M. Successful strategies in atopic dermatitis management. Dermatol Nurs. 2008 Oct; Suppl:3-18; quiz 19. PMID: 19102292.
      View in: PubMed
    42. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc. 2008 Sep-Oct; 29(5):433-8. PMID: 18926050.
      View in: PubMed
    43. Rancé F, Boguniewicz M, Lau S. New visions for atopic eczema: an iPAC summary and future trends. Pediatr Allergy Immunol. 2008 Aug; 19 Suppl 19:17-25. PMID: 18665960.
      View in: PubMed
    44. Kisich KO, Carspecken CW, Fiéve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol. 2008 Jul; 122(1):62-8. PMID: 18538383.
      View in: PubMed
    45. Boguniewicz M, Nicol N, Kelsay K, Leung DY. A multidisciplinary approach to evaluation and treatment of atopic dermatitis. Semin Cutan Med Surg. 2008 Jun; 27(2):115-27. PMID: 18620133.
      View in: PubMed
    46. Langley RG, Eichenfield LF, Lucky AW, Boguniewicz M, Barbier N, Cherill R. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis. Pediatr Dermatol. 2008 May-Jun; 25(3):301-7. PMID: 18577032.
      View in: PubMed
    47. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, Hansen KC, Leung DY. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol. 2008 Sep; 128(9):2248-58. PMID: 18385759.
      View in: PubMed
    48. Ong PY, Boguniewicz M. Atopic dermatitis. Prim Care. 2008 Mar; 35(1):105-17, vii. PMID: 18206720.
      View in: PubMed
    49. Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr. 2008 Jun; 152(6):854-9. PMID: 18492531.
      View in: PubMed
    50. Abramovits W, Hebert AA, Boguniewicz M, Kempers SE, Tschen E, Jarratt MT, Lucky AW, Cornelison RL, Swinyer LJ, Jones TM. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults. J Dermatolog Treat. 2008; 19(6):327-32. PMID: 18728923.
      View in: PubMed
    51. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008 Mar; 126(3):332-7. PMID: 18166499; PMCID: PMC2275206.
    52. Spergel JM, Boguniewicz M, Paller AS, Hebert AA, Gallagher PR, McCormick C, Parneix-Spake A, Hultsch T. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. Br J Dermatol. 2007 Aug; 157(2):378-81. PMID: 17573885.
      View in: PubMed
    53. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007 Jul; 120(1):150-5. PMID: 17512043; PMCID: PMC2669594.
    54. Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, Leung DY. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol. 2007 Oct; 127(10):2368-80. PMID: 17460726.
      View in: PubMed
    55. Boguniewicz M, Abramovits W, Paller A, Whitaker-Worth DL, Prendergast M, Cheng JW, Wang P, Tong KB. A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. J Drugs Dermatol. 2007 Apr; 6(4):416-23. PMID: 17668539.
      View in: PubMed
    56. Salt BH, Boguniewicz M, Leung DY. Severe refractory atopic dermatitis in adults is highly atopic. J Allergy Clin Immunol. 2007 Feb; 119(2):508-9. PMID: 17194471.
      View in: PubMed
    57. Kim BE, Leung DY, Streib JE, Kisich K, Boguniewicz M, Hamid QA, Howell MD. Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol. 2007 Feb; 119(2):457-63. PMID: 17141855; PMCID: PMC2746067.
    58. Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, Leung DY. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol. 2006 Dec; 121(3):332-8. PMID: 17015038.
      View in: PubMed
    59. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy. 2006 Aug; 61(8):969-87. PMID: 16867052.
      View in: PubMed
    60. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006 Jul; 118(1):152-69. PMID: 16815151.
      View in: PubMed
    61. Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J Allergy Clin Immunol. 2006 Jul; 118(1):40-3. PMID: 16815136.
      View in: PubMed
    62. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DY. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006 Mar; 24(3):341-8. PMID: 16546102.
      View in: PubMed
    63. Abramovits W, Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006 Mar; 5(3):236-44. PMID: 16573256.
      View in: PubMed
    64. Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DY. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol. 2006 Apr; 117(4):836-41. PMID: 16630942; PMCID: PMC2727734.
    65. Boguniewicz M, Leung DY. 10. Atopic dermatitis. J Allergy Clin Immunol. 2006 Feb; 117(2 Suppl Mini-Primer):S475-80. PMID: 16455350.
      View in: PubMed
    66. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Boguniewcz M, Yao L, Storey H, LeCiel C, Harder B, Gross JA. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2006 Feb; 117(2):418-25. PMID: 16461143.
      View in: PubMed
    67. Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewicz M, Streib J, Wong C, Gallo RL, Leung DY. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol. 2005 Oct; 125(4):738-45. PMID: 16185274.
      View in: PubMed
    68. Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Pediatrics. 2005 Sep; 116(3):e334-42. PMID: 16140675.
      View in: PubMed
    69. Chapman MS, Schachner LA, Breneman D, Boguniewicz M, Gold MH, Shull T, Linowski GJ, Jaracz E. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. J Am Acad Dermatol. 2005 Aug; 53(2 Suppl 2):S177-85. PMID: 16021173.
      View in: PubMed
    70. Fonacier L, Spergel J, Charlesworth EN, Weldon D, Beltrani V, Bernhisel-Broadbent J, Boguniewicz M, Leung DY. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2005 Jun; 115(6):1249-53. PMID: 15940142.
      View in: PubMed
    71. Boguniewicz M. Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am. 2005 May; 25(2):333-51, vii. PMID: 15878459.
      View in: PubMed
    72. Abramovits W, Boguniewicz M, Paller AS, Whitaker-Worth DL, Prendergast MM, Tokar M, Tong KB. The economics of topical immunomodulators for the treatment of atopic dermatitis. Pharmacoeconomics. 2005; 23(6):543-66. PMID: 15960552.
      View in: PubMed
    73. Boguniewicz M. Chronic urticaria in children. Allergy Asthma Proc. 2005 Jan-Feb; 26(1):13-7. PMID: 15813283.
      View in: PubMed
    74. Boguniewicz M. Topical treatment of atopic dermatitis. Immunol Allergy Clin North Am. 2004 Nov; 24(4):631-44, vi-vii. PMID: 15474863.
      View in: PubMed
    75. Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, Stiller M, Tschen E, Chon K, Wisseh S, Abrams B. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol. 2004 Oct; 51(4):515-25. PMID: 15389185.
      View in: PubMed
    76. Leung DY, Nicklas RA, Li JT, Bernstein IL, Blessing-Moore J, Boguniewicz M, Chapman JA, Khan DA, Lang D, Lee RE, Portnoy JM, Schuller DE, Spector SL, Tilles SA. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004 Sep; 93(3 Suppl 2):S1-21. PMID: 15478395.
      View in: PubMed
    77. Boguniewicz M. Update on atopic dermatitis: insights into pathogenesis and new treatment paradigms. Allergy Asthma Proc. 2004 Sep-Oct; 25(5):279-82. PMID: 15603199.
      View in: PubMed
    78. Prendergast MM, Abramovits W, Boguniewicz M, Lebwohl M, Tokar M, Tong KB. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology. J Invest Dermatol. 2004 Sep; 123(3):452-4. PMID: 15304081.
      View in: PubMed
    79. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004 Mar; 113(5):651-7. PMID: 14991059; PMCID: PMC351324.
    80. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003 Dec; 112(6):1195-202. PMID: 14657882.
      View in: PubMed
    81. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol. 2003 Dec; 112(6 Suppl):S140-50. PMID: 14657844.
      View in: PubMed
    82. Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K. 1% pimecrolimus cream for atopic dermatitis. Arch Dermatol. 2003 Oct; 139(10):1369-70; author reply 1370-1. PMID: 14568846.
      View in: PubMed
    83. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003 Sep 15; 171(6):3262-9. PMID: 12960356.
      View in: PubMed
    84. Boguniewicz M. Treatment options and new therapeutic approaches in atopic dermatitis. Dermatol Nurs. 2003 Aug; Suppl:12-8. PMID: 14520893.
      View in: PubMed
    85. Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, Christodoulopoulos P, Fukuda T, Elias JA, Hamid QA. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol. 2003 Apr; 111(4):875-81. PMID: 12704372.
      View in: PubMed
    86. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Paller AS, Stevens SR, Whitaker-Worth DL, Tong KB. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol. 2003 Apr; 48(4):553-63. PMID: 12664019.
      View in: PubMed
    87. Leung DY, Boguniewicz M. Advances in allergic skin diseases. J Allergy Clin Immunol. 2003 Mar; 111(3 Suppl):S805-12. PMID: 12618747.
      View in: PubMed
    88. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Tong KB. Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema. Pharmacoeconomics. 2003; 21(12):875-83. PMID: 12908843.
      View in: PubMed
    89. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002 Oct 10; 347(15):1151-60. PMID: 12374875.
      View in: PubMed
    90. Boguniewicz M. Combination therapy and new directions for managing atopic dermatitis. Allergy Asthma Proc. 2002 Jul-Aug; 23(4):243-6. PMID: 12221893.
      View in: PubMed
    91. Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 2002 Apr; 46(4):495-504. PMID: 11907497.
      View in: PubMed
    92. Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol. 2002 Apr 01; 168(7):3627-34. PMID: 11907128.
      View in: PubMed
    93. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002 Mar; 46(3):361-70. PMID: 11862170.
      View in: PubMed
    94. Ong PY, Hamid QA, Travers JB, Strickland I, Al Kerithy M, Boguniewicz M, Leung DY. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol. 2002 Jan 01; 168(1):505-10. PMID: 11751999.
      View in: PubMed
    95. Boguniewicz M, Leung DY. Pathophysiologic mechanisms in atopic dermatitis. Semin Cutan Med Surg. 2001 Dec; 20(4):217-25. PMID: 11770908.
      View in: PubMed
    96. Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DY. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001 Oct; 108(4):651-2. PMID: 11590398.
      View in: PubMed
    97. Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol. 2001 Aug; 108(2):269-74. PMID: 11496245.
      View in: PubMed
    98. Taha RA, Minshall EM, Leung DY, Boguniewicz M, Luster A, Muro S, Toda M, Hamid QA. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol. 2000 May; 105(5):1002-7. PMID: 10808183.
      View in: PubMed
    99. Nicol NH, Boguniewicz M. Understanding and treating atopic dermatitis. Nurse Pract Forum. 1999 Jun; 10(2):48-55. PMID: 10542581.
      View in: PubMed
    100. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol. 1998 Oct; 102(4 Pt 1):645-50. PMID: 9802374.
      View in: PubMed
    101. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol. 1998 Oct; 102(4 Pt 1):637-44. PMID: 9802373.
      View in: PubMed
    102. Taha RA, Leung DY, Ghaffar O, Boguniewicz M, Hamid Q. In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol. 1998 Aug; 102(2):245-50. PMID: 9723668.
      View in: PubMed
    103. Boguniewicz M, Leung DY. Atopic dermatitis: a question of balance. Arch Dermatol. 1998 Jul; 134(7):870-1. PMID: 9681355.
      View in: PubMed
    104. Boguniewicz M. Advances in the understanding and treatment of atopic dermatitis. Curr Opin Pediatr. 1997 Dec; 9(6):577-81. PMID: 9425590.
      View in: PubMed
    105. Rothenberg SS, Bratton D, Larsen G, Deterding R, Milgrom H, Brugman S, Boguniewicz M, Copenhaver S, White C, Wagener J, Fan L, Chang J, Stathos T. Laparoscopic fundoplication to enhance pulmonary function in children with severe reactive airway disease and gastroesophageal reflux disease. Surg Endosc. 1997 Nov; 11(11):1088-90. PMID: 9348380.
      View in: PubMed
    106. Boguniewicz M, Hayward A. Atopy, airway responsiveness, and genes. Thorax. 1996 Aug; 51 Suppl 2:S55-9. PMID: 8869354; PMCID: PMC1090708.
    107. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol. 1996 Jul; 98(1):225-31. PMID: 8765838.
      View in: PubMed
    108. Landwehr LP, Boguniewicz M. Current perspectives on latex allergy. J Pediatr. 1996 Mar; 128(3):305-12. PMID: 8774495.
      View in: PubMed
    109. Boguniewicz M, Leung DY. New concepts in atopic dermatitis. Compr Ther. 1996 Mar; 22(3):144-51. PMID: 8706383.
      View in: PubMed
    110. Boguniewicz M, Leung DY. Hypersensitivity reactions to antibiotics commonly used in children. Pediatr Infect Dis J. 1995 Mar; 14(3):221-31. PMID: 7761188.
      View in: PubMed
    111. Boguniewicz M, Martin RJ, Martin D, Gibson U, Celniker A, Williams M, Leung DY. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol. 1995 Jan; 95(1 Pt 1):133-5. PMID: 7822655.
      View in: PubMed
    112. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DY. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest. 1995 Jan; 95(1):211-8. PMID: 7814618; PMCID: PMC295407.
    113. Abernathy-Carver KJ, Fan LL, Boguniewicz M, Larsen GL, Leung DY. Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol. 1994 Sep; 18(3):135-8. PMID: 7800428.
      View in: PubMed
    114. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 1994 Aug; 94(2):870-6. PMID: 8040343; PMCID: PMC296169.
    115. Martin RJ, Boguniewicz M, Henson JE, Celniker AC, Williams M, Giorno RC, Leung DY. The effects of inhaled interferon gamma in normal human airways. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1677-82. PMID: 8256919.
      View in: PubMed
    116. Boguniewicz M, Schneider LC, Milgrom H, Newell D, Kelly N, Tam P, Izu AE, Jaffe HS, Bucalo LR, Leung DY. Treatment of steroid-dependent asthma with recombinant interferon-gamma. Clin Exp Allergy. 1993 Sep; 23(9):785-90. PMID: 10779310.
      View in: PubMed
    117. Boguniewicz M, Leung DY. Management of the patient with allergic reactions to antibiotics. Pediatr Pulmonol. 1992 Feb; 12(2):113-22. PMID: 1570189.
      View in: PubMed
    118. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr. 1991 Apr; 118(4 Pt 1):633-7. PMID: 1901084.
      View in: PubMed
    119. Boguniewicz M, Jaffe HS, Izu A, Sullivan MJ, York D, Geha RS, Leung DY. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med. 1990 Apr; 88(4):365-70. PMID: 2109531.
      View in: PubMed
    Boguniewicz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)